Connect Biopharma Holdings (CNTB)
(Delayed Data from NSDQ)
$1.57 USD
-0.04 (-2.48%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.57 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Connect Biopharma Holdings Limited Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CNTB 1.57 -0.04(-2.48%)
Will CNTB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CNTB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNTB
What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?
CNTB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CNTB
CNTB falls 2.48% on September 19, leaving the technical picture intact
Is CNTB about to break its pattern? NR7 shows up after a flat session
Stochastic Buy Signal appears for CNTB after 0.0% move
CNTB's price rises by 0.63% on September 16, though its technical setup remains stable.
Connect Biopharma Executives Increase Share Holdings